BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 7902375)

  • 1. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
    Evans CF; Rall GF; Killeen N; Littman D; Oldstone MB
    J Immunol; 1993 Dec; 151(11):6259-64. PubMed ID: 7902375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of large granular T lymphocytes in vivo during viral infection.
    Biron CA; Natuk RJ; Welsh RM
    J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice.
    Thomsen AR; Johansen J; Marker O; Christensen JP
    J Immunol; 1996 Oct; 157(7):3074-80. PubMed ID: 8816417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
    Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
    Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
    Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
    Walker CM; Paetkau V; Rawls WE; Rosenthal KL
    J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
    Razvi ES; Welsh RM; McFarland HI
    J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
    Bocharov GA
    J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus.
    Baenziger J; Hengartner H; Zinkernagel RM; Cole GA
    Eur J Immunol; 1986 Apr; 16(4):387-93. PubMed ID: 3084281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection.
    Selin LK; Welsh RM
    J Immunol; 1997 Jun; 158(11):5366-73. PubMed ID: 9164957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal intraepithelial lymphocytes respond to systemic lymphocytic choriomeningitis virus infection.
    Sydora BC; Jamieson BD; Ahmed R; Kronenberg M
    Cell Immunol; 1996 Feb; 167(2):161-9. PubMed ID: 8603424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
    McFarland HI; Nahill SR; Maciaszek JW; Welsh RM
    J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.